1 | reason | 3,078 |
2 | rationale | 2,185 |
3 | justification | 405 |
4 | prerequisite | 365 |
5 | quest | 161 |
6 | timeline | 119 |
7 | impetus | 118 |
8 | denominator | 101 |
9 | precondition | 66 |
10 | groundwork | 54 |
11 | motivator | 40 |
12 | panacea | 32 |
13 | pre-requisite | 22 |
14 | blueprint | 19 |
15 | udvalg | 19 |
16 | time-line | 14 |
17 | ic50-values | 10 |
18 | resynchronization-defibrillation | 10 |
19 | no-observed-adverse-effect-level | 7 |
20 | pre-condition | 7 |
21 | gavs | 5 |
22 | disease-management-programme | 4 |
23 | gained/month | 4 |
24 | optimums | 4 |
25 | cis-golgi | 3 |
26 | e-site | 3 |
27 | indr | 3 |
28 | pleas | 3 |
29 | tendancy | 3 |
30 | 341.1 | 2 |
31 | age-receptor | 2 |
32 | challenger | 2 |
33 | counterreceptor | 2 |
34 | glycopegylation | 2 |
35 | icl-index | 2 |
36 | ns-adr | 2 |
37 | photopigment | 2 |
38 | riskfactor | 2 |
39 | tcm-sf | 2 |
40 | thermodisinfection | 2 |
41 | treatment/day | 2 |
42 | trial.data | 2 |
43 | 0.59/m | 1 |
44 | 1,525-2,076 | 1 |
45 | 1.11/m | 1 |
46 | 156.82 | 1 |
47 | 308.22 | 1 |
48 | 313.1 | 1 |
49 | 352.30 | 1 |
50 | 355.30 | 1 |
51 | 359.30 | 1 |
52 | 483,000 | 1 |
53 | 538.2 | 1 |
54 | 736-768 | 1 |
55 | 795-829 | 1 |
56 | 868-884 | 1 |
57 | acupints | 1 |
58 | aminosid | 1 |
59 | antiprotozoarian | 1 |
60 | aupoint | 1 |
61 | bag/day | 1 |
62 | centres-nor | 1 |
63 | component/event | 1 |
64 | contraindictions | 1 |
65 | farmulations | 1 |
66 | fiddle | 1 |
67 | forename | 1 |
68 | gapdh-cp12 | 1 |
69 | hinderance | 1 |
70 | lipid-sensitive | 1 |
71 | outcomes-as | 1 |
72 | p-π | 1 |
73 | phono-hemodynamic | 1 |
74 | reference-compounds | 1 |
75 | sub-stratification | 1 |
76 | sugar-converting | 1 |
77 | superprecision | 1 |
78 | time-effects | 1 |
79 | wet-cough | 1 |
80 | yahoo.com | 1 |
1 | 0.59/m | 1 |
2 | 1,525-2,076 | 1 |
3 | 1.11/m | 1 |
4 | 156.82 | 1 |
5 | 308.22 | 1 |
6 | 313.1 | 1 |
7 | 341.1 | 2 |
8 | 352.30 | 1 |
9 | 355.30 | 1 |
10 | 359.30 | 1 |
11 | 483,000 | 1 |
12 | 538.2 | 1 |
13 | 736-768 | 1 |
14 | 795-829 | 1 |
15 | 868-884 | 1 |
16 | acupints | 1 |
17 | age-receptor | 2 |
18 | aminosid | 1 |
19 | antiprotozoarian | 1 |
20 | aupoint | 1 |
21 | bag/day | 1 |
22 | blueprint | 19 |
23 | centres-nor | 1 |
24 | challenger | 2 |
25 | cis-golgi | 3 |
26 | component/event | 1 |
27 | contraindictions | 1 |
28 | counterreceptor | 2 |
29 | denominator | 101 |
30 | disease-management-programme | 4 |
31 | e-site | 3 |
32 | farmulations | 1 |
33 | fiddle | 1 |
34 | forename | 1 |
35 | gained/month | 4 |
36 | gapdh-cp12 | 1 |
37 | gavs | 5 |
38 | glycopegylation | 2 |
39 | groundwork | 54 |
40 | hinderance | 1 |
41 | ic50-values | 10 |
42 | icl-index | 2 |
43 | impetus | 118 |
44 | indr | 3 |
45 | justification | 405 |
46 | lipid-sensitive | 1 |
47 | motivator | 40 |
48 | no-observed-adverse-effect-level | 7 |
49 | ns-adr | 2 |
50 | optimums | 4 |
51 | outcomes-as | 1 |
52 | p-π | 1 |
53 | panacea | 32 |
54 | phono-hemodynamic | 1 |
55 | photopigment | 2 |
56 | pleas | 3 |
57 | pre-condition | 7 |
58 | pre-requisite | 22 |
59 | precondition | 66 |
60 | prerequisite | 365 |
61 | quest | 161 |
62 | rationale | 2,185 |
63 | reason | 3,078 |
64 | reference-compounds | 1 |
65 | resynchronization-defibrillation | 10 |
66 | riskfactor | 2 |
67 | sub-stratification | 1 |
68 | sugar-converting | 1 |
69 | superprecision | 1 |
70 | tcm-sf | 2 |
71 | tendancy | 3 |
72 | thermodisinfection | 2 |
73 | time-effects | 1 |
74 | time-line | 14 |
75 | timeline | 119 |
76 | treatment/day | 2 |
77 | trial.data | 2 |
78 | udvalg | 19 |
79 | wet-cough | 1 |
80 | yahoo.com | 1 |
1 | 483,000 | 1 |
2 | 352.30 | 1 |
3 | 355.30 | 1 |
4 | 359.30 | 1 |
5 | 341.1 | 2 |
6 | 313.1 | 1 |
7 | 538.2 | 1 |
8 | gapdh-cp12 | 1 |
9 | 308.22 | 1 |
10 | 156.82 | 1 |
11 | 868-884 | 1 |
12 | 1,525-2,076 | 1 |
13 | 736-768 | 1 |
14 | 795-829 | 1 |
15 | panacea | 32 |
16 | trial.data | 2 |
17 | phono-hemodynamic | 1 |
18 | aminosid | 1 |
19 | hinderance | 1 |
20 | rationale | 2,185 |
21 | fiddle | 1 |
22 | forename | 1 |
23 | disease-management-programme | 4 |
24 | time-line | 14 |
25 | timeline | 119 |
26 | e-site | 3 |
27 | pre-requisite | 22 |
28 | prerequisite | 365 |
29 | lipid-sensitive | 1 |
30 | tcm-sf | 2 |
31 | udvalg | 19 |
32 | sugar-converting | 1 |
33 | wet-cough | 1 |
34 | gained/month | 4 |
35 | cis-golgi | 3 |
36 | groundwork | 54 |
37 | no-observed-adverse-effect-level | 7 |
38 | 1.11/m | 1 |
39 | 0.59/m | 1 |
40 | yahoo.com | 1 |
41 | antiprotozoarian | 1 |
42 | superprecision | 1 |
43 | sub-stratification | 1 |
44 | justification | 405 |
45 | resynchronization-defibrillation | 10 |
46 | glycopegylation | 2 |
47 | thermodisinfection | 2 |
48 | pre-condition | 7 |
49 | precondition | 66 |
50 | reason | 3,078 |
51 | ns-adr | 2 |
52 | indr | 3 |
53 | challenger | 2 |
54 | centres-nor | 1 |
55 | denominator | 101 |
56 | motivator | 40 |
57 | riskfactor | 2 |
58 | age-receptor | 2 |
59 | counterreceptor | 2 |
60 | outcomes-as | 1 |
61 | pleas | 3 |
62 | reference-compounds | 1 |
63 | ic50-values | 10 |
64 | optimums | 4 |
65 | farmulations | 1 |
66 | contraindictions | 1 |
67 | time-effects | 1 |
68 | acupints | 1 |
69 | impetus | 118 |
70 | gavs | 5 |
71 | photopigment | 2 |
72 | component/event | 1 |
73 | aupoint | 1 |
74 | blueprint | 19 |
75 | quest | 161 |
76 | icl-index | 2 |
77 | bag/day | 1 |
78 | treatment/day | 2 |
79 | tendancy | 3 |
80 | p-π | 1 |